Highly sensitive method for the determination of tamsulosin hydrochloride in human plasma dialysate, plasma and urine by high-performance liquid chromatography electrospray tandem mass spectrometry

A highly sensitive method for the determination of tamsulosin hydrochloride, a structurally new type of sulphamoile derivative, in human plasma dialysate, plasma and urine has been developed by using liquid chromatography-electrospray tandem mass spectrometry (LC-MS-MS). Plasma dialysate, plasma and urine samples were extracted by brief Liquid-phase extraction and analyzed using an HPLC system coupled to a mass spectrometer via an electrospray ionization interface. Selected reaction monitoring was used for the detection of tamsulosin and its internal standard. This method was Validated in the concentration range 10-1000 pg/ml in plasma dialysate, 0.5-50 ng/ml in plasma, and 1-100 ng/ml in urine with sufficient Specificity, accuracy and precision. The in vivo protein binding study demonstrated that the unbound tamsulosin in human plasma obtained by the equilibrium dialysis after 0.4-mg oral dosing was measurable. Tn addition, the percentage of unbound tamsulosin in an in vitro study (0.71-0.91%) obtained by using spiked C-14-labelled tamsulosin was slightly larger than that of the in vivo study (0.68-0.86%), indicating that the unbound concentration calculated by the product of the plasma concentration and the in vitro unbound fraction (fu) was unfavorably overestimated. These results suggest that the combination of LC-MS-MS and equilibrium dialysis method has enough sensitivity to determine the unbound concentration in clinical use and gives the concentration more exactly than the in vitro fu. (C) 1997 Elsevier Science B.V.